Targeted modulation of MGMT: clinical implications
- PMID: 16428468
- DOI: 10.1158/1078-0432.CCR-05-2543
Targeted modulation of MGMT: clinical implications
Abstract
O(6)-Methylguanine DNA methyltransferase (MGMT) has been studied for >20 years as a gene that is associated with the mutagenicity and cytotoxicity induced by either methylating carcinogens or alkylating (methylating and chloroethylating) therapeutic agents. Pioneering studies of alkylating agents identified alkylated guanine at the O(6) position, the substrate of MGMT, as a potentially promutagenic and lethal toxic DNA lesion. MGMT plays a prominent role in DNA adduct repair that limits the mutagenic and cytotoxic effect of alkylating agents. Because of its role in cancer etiology and chemotherapy resistance, MGMT is of particular interest. In this article, the clinical effect of MGMT expression and targeted modulation of MGMT will be summarized.
Similar articles
-
Alterations in S-adenosylhomocysteine metabolism decrease O6-methylguanine DNA methyltransferase gene expression without affecting promoter methylation.Biochem Pharmacol. 2008 Jun 1;75(11):2100-11. doi: 10.1016/j.bcp.2008.02.031. Epub 2008 Mar 8. Biochem Pharmacol. 2008. PMID: 18395186
-
MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.DNA Repair (Amst). 2007 Aug 1;6(8):1079-99. doi: 10.1016/j.dnarep.2007.03.008. Epub 2007 May 7. DNA Repair (Amst). 2007. PMID: 17485253 Review.
-
MGMT hypermethylation: a prognostic foe, a predictive friend.DNA Repair (Amst). 2007 Aug 1;6(8):1155-60. doi: 10.1016/j.dnarep.2007.03.013. Epub 2007 May 7. DNA Repair (Amst). 2007. PMID: 17482895 Review.
-
Epigenetic silencing of the MGMT gene in cancer.Biochem Cell Biol. 2005 Aug;83(4):429-37. doi: 10.1139/o05-140. Biochem Cell Biol. 2005. PMID: 16094446 Review.
-
Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer.Oncogene. 2004 Jan 8;23(1):1-8. doi: 10.1038/sj.onc.1207316. Oncogene. 2004. PMID: 14712205 Review.
Cited by
-
MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma.Sci Rep. 2024 May 29;14(1):12363. doi: 10.1038/s41598-024-61240-x. Sci Rep. 2024. PMID: 38811596 Free PMC article.
-
'The Reports of My Death Are Greatly Exaggerated'-Evaluating the Effect of Necrosis on MGMT Promoter Methylation Testing in High-Grade Glioma.Cancers (Basel). 2024 May 16;16(10):1906. doi: 10.3390/cancers16101906. Cancers (Basel). 2024. PMID: 38791984 Free PMC article.
-
A case report: Gliosarcoma associated with a germline heterozygous mutation in MSH2.Front Neurol. 2024 May 9;15:1388263. doi: 10.3389/fneur.2024.1388263. eCollection 2024. Front Neurol. 2024. PMID: 38784900 Free PMC article.
-
Base flipping mechanism and binding strength of methyl-damaged DNA during the interaction with AGT.J Biol Phys. 2024 Mar;50(1):71-87. doi: 10.1007/s10867-023-09649-9. Epub 2023 Dec 27. J Biol Phys. 2024. PMID: 38150168
-
Molecular Biomarkers and Recent Liquid Biopsy Testing Progress: A Review of the Application of Biosensors for the Diagnosis of Gliomas.Molecules. 2023 Jul 26;28(15):5660. doi: 10.3390/molecules28155660. Molecules. 2023. PMID: 37570630 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials